From: Mortality & recurrent seizure risk after new-onset seizure in HIV-positive Zambian adults
Characteristic | Hazard Ratio [95% CI] | P-value a |
---|---|---|
Gender, female | 0.9 [0.5–1.7] | 0.745 |
Age, mean | 1.01 [0.98–1.05] | 0.383 |
WHO HIV clinical stage III or IVb | 19.1 [1.1–333.4] | 0.01 |
cART use at enrollment | 1.5 [0.8–2.9] | 0.240 |
Karnofsky score < 50 at enrollment | 1.8 [0.9–3.8] | 0.125 |
Seizure severity at enrollment | ||
 Brief, Single | Referent | 0.173 |
 Multiple, prolonged | 1.7 [0.7–3.9] |  |
 Status epilepticus | 2.6 [0.96–7.3] |  |
CNS opportunistic infection | 0.9 [0.4–2.2] | 0.889 |
Unknown etiology | 2.2 [1.1–4.4] | 0.025 |
Among those with CSF (n = 61) | 2.1 [0.8–5.3] | 0.129 |